- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. freshman Avg
|
- 10-K Annual report
- 12.1 Ratio of Earnings to Fixed Charges
- 21.1 Subsidiaries
- 23.1 Consent of Independent Registered Public Accounting Firm
- 31.1 Rule 13A-14(A) Section 302 Certification
- 31.2 Rule 13A-14(A) Section 302 Certification
- 32.1 Certificate Pursuant to 18 U.s.c. Section 1350
- 32.2 Certificate Pursuant to 18 U.s.c. Section 1350
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in the Registration Statements (Form S-8 Nos. 333-120405, 333-108390, 333-98939, 333-86110, 333-47400, 333-61224 and 333-76622) pertaining to the DURECT Corporation 1998 Incentive Stock Plan, the DURECT Corporation 2000 Employee Stock Purchase Plan, the DURECT Corporation 2000 Stock Plan, the DURECT Corporation 2000 Directors’ Stock Option Plan, the Southern BioSystems, Inc. 1993 Stock Option Plan and the Southern Research Technologies, Inc. 1995 Nonqualified Stock Option Plan and in the Registration Statements (Form S-3 Nos. 333-108398 and 333-108396) of DURECT Corporation of our reports dated March 10, 2005, with respect to the consolidated financial statements and schedule of DURECT Corporation, DURECT Corporation management’s assessment of the effectiveness of internal control over financial reporting, and the effectiveness of internal control over financial reporting of DURECT Corporation included in this Annual Report (Form 10-K) for the year ended December 31, 2004.
/s/ ERNST & YOUNG LLP
Palo Alto, California
March 10, 2005